Histiocitosis de células de Langerhans e imágenes diagnósticas

Samuel Rosas Saldarriaga

Resumen


El objetivo del artículo es presentar el caso de un paciente que consultó al servicio de imaginología por dolor en la región costal, el cual posteriormente fue diagnosticado como histiocitosis de células de Langerhans. Se pretende proveer al lector una breve revisión de tema de imágenes diagnósticas de esta enfermedad, para que el reconocimiento de la misma permanezca dentro de la lista de diagnósticos diferenciales.

DOI: http://dx.doi.org/10.21615/cesmedicina.30.2.11


Palabras clave


langerhans; histiocitosis;histiocytosis

Citas


Mohammed A, Abdullahi K, Mohammed U, Aliyu HO, Liman AA, Abdullahi S, et al. Disseminated Langerhan's cell histiocytosis: a case report and review of the literature. Annals of African medicine. 2011 ;10(4):310-3.. https://www.ncbi.nlm.nih.gov/pubmed/22064259

Klemke CD, Dippel E, Geilen CC, Koenigsmann MP, Thiel E, Orfanos CE, et al. Atypical generalized eruptive histiocytosis associated with acute monocytic leukemia. Journal of the American Academy of Dermatology. 2003 Nov;49(5 Suppl):S233-6.. http://www.jaad.org/article/S0190-9622(03)00037-9/abstract

Zhong WQ, Jiang L, Ma QJ, Liu ZJ, Liu XG, Wei F, et al. Langerhans cell histiocytosis of the atlas in an adult. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2010 Jan;19(1):19-22.. https://www.ncbi.nlm.nih.gov/pubmed/19844749

Wilejto M, Abla O. Langerhans cell histiocytosis and Erdheim-Chester disease. Current opinion in rheumatology. 2012 Jan;24(1):90-6. https://www.ncbi.nlm.nih.gov/pubmed/22157416

Sieben NL, Macropoulos P, Roemen GM, Kolkman-Uljee SM, Jan Fleuren G, Houmadi R, et al. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. The Journal of pathology. 2004 Mar;202(3):336-40. https://www.ncbi.nlm.nih.gov/pubmed/14991899

Singer G, Oldt R, 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. Journal of the National Cancer Institute. 2003 Mar 19;95(6):484-6. https://www.ncbi.nlm.nih.gov/pubmed/12644542

Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. The Journal of clinical endocrinology and metabolism. 2007 Nov;92(11):4085-90.. https://www.ncbi.nlm.nih.gov/pubmed/17785355

Mayr D, Hirschmann A, Lohrs U, Diebold J. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecologic oncology. 2006 Dec;103(3):883-7. https://www.ncbi.nlm.nih.gov/pubmed/16806438

Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011; 117(19):5019-32.. http://www.bloodjournal.org/content/117/19/5019?sso-checked=true

Yildirim-Baylan M, Cureoglu S, Paparella MM. Temporal Bone Histopathology Case of the Month: Langerhans’ Cell Histiocytosis of the Temporal Bone. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2012;33(2):10.1097/MAO.0b013e31821a80f8.

Juvet SC, Hwang D, Downey GP. Rare lung diseases III: Pulmonary Langerhans’ cell histiocytosis. Canadian Respiratory Journal : Journal of the Canadian Thoracic Society. 2010 May-Jun;17(3):e55-e62. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900147/

Xia CX, Li R, Wang ZH, Lv FJ, Tang XQ, Li QF, et al. A rare cause of goiter: Langerhans cell histiocytosis of the thyroid. Endocrine journal. 2012;59(1):47-54. https://www.ncbi.nlm.nih.gov/pubmed/22019948

Azouz EM, Saigal G, Rodriguez M, Podda A. Langerhans’ cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol. 2005 2005/02/01;35(2):103-15. https://www.ncbi.nlm.nih.gov/pubmed/15289942

Stull MA, Kransdorf MJ, Devaney KO. Langerhans cell histiocytosis of bone. RadioGraphics. 1992 1992/07/01;12(4):801-23. https://www.ncbi.nlm.nih.gov/pubmed/1636041

Grois N, Potschger U, Prosch H, Minkov M, Arico M, Braier J, et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatric blood & cancer. 2006 Feb;46(2):228-33. https://www.ncbi.nlm.nih.gov/pubmed/16047354

Hung PC, Wang HS, Jaing TH, Huang TJ, Pang LC. From normal to abnormal MR findings within three weeks in a solitary pelvic Langerhans histiocytosis. Skeletal radiology. 2003 Aug;32(8):481-4. http://link.springer.com/article/10.1007/s00256-003-0637-x

Huang WD, Yang XH, Wu ZP, Huang Q, Xiao JR, Yang MS, et al. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults. The spine journal : official journal of the North American Spine Society. 2013 Sep;13(9):1108-17. https://www.ncbi.nlm.nih.gov/pubmed/23602327

Hwang S, Panicek DM. The evolution of musculoskeletal tumor imaging. Radiologic clinics of North America. 2009 May;47(3):435-53. https://www.ncbi.nlm.nih.gov/pubmed/19361669

National Cancer Institute: PDQ® Langerhans Cell Histiocytosis Treatment. Bethesda, MD: National Cancer Institute. Date last modified <01/30/2015>. Available at: http://cancer.gov/cancertopics/pdq/treatment/lchistio/HealthProfessional.


Texto completo: PDF

Refbacks

  • No hay Refbacks actualmente.




Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

 

Revista CES Medicina/ ISSN Impreso:0120-8705; Electrónico:2215-9177

Facultad de Medicina, Universidad CES.

 

Publicada desde 1987.

 

Universidad CES - Facultad de Medicina
Calle 10A No. 22 - 04 Tel: 444 05 55 Fax: 268 28 76 Correo electrónico: revistamedica@ces.edu.co Medellín – Colombia

 

http://www.ces.edu.co/